Kezar Life Sciences
About:
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Website: https://kezarlifesciences.com/
Top Investors: Qiming Venture Partners, Cormorant Asset Management, EcoR1 Capital, Cowen Group, Morningside Venture Investments
Description:
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders. In parallel with this work, Christopher and Kezar co-founder Jack Taunton, Ph.D. collaborated on several research projects involving protein secretion. This collaboration inspired a belief in the strong synergies between protein degradation and protein secretion, two fertile areas for drug discovery with platform potential.
$135M
$1M to $10M
South San Francisco, California, United States
2015-01-01
contact(AT)kezarbio.com
Christopher Kirk, Jack Taunton, John Fowler
51-100
2022-10-03
Public
© 2025 bioDAO.ai